InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (13 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
13
T+90 hit rate
52%
T+90 mean return
+14.9%
Across 61 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Dudum Andrew, Chief Executive Officer. Officer active across 1 company, notably Hims & Hers Health, Inc.. In total, 76 reports have been published. Breakdown: 4 buys · 13 sells. Total volume traded: €13.7m. History available since 24 May 2021. The latest transaction was disclosed on 17 September 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations76 total
154,991 sharesClass A Common StockSEC:0001773751-26-000126:0
85,632 sharesClass A Common StockSEC:0001773751-26-000126:1
65,110 shares@ US$50.574522.2% of flowClass A Common StockSEC:0001773751-25-000311
65,110 shares@ US$50.57450.038% mcap22.2% of flowClass A Common StockSEC:0001773751-25-000311:0
2,792 shares@ US$59.27010.6% of flowClass A Common StockSEC:0001773751-25-000165:0
41,667 shares@ US$2.430.3% of flowClass A Common StockSEC:0001773751-25-000141:0
41,667 shares@ US$30.1864.2% of flowClass A Common StockSEC:0001773751-25-000141:1
50,000 shares@ US$2.430.4% of flowClass A Common StockSEC:0001773751-25-000141:2
50,000 shares@ US$36.38626.1% of flowClass A Common StockSEC:0001773751-25-000141:3
17,001 shares@ US$2.430.1% of flowClass A Common StockSEC:0001773751-25-000124:0
176,311 sharesClass A Common StockSEC:0001773751-25-000101:0
1,992 shares@ US$58.34570.4% of flowClass A Common StockSEC:0001773751-25-000051:0
3,159 sharesClass A Common StockSEC:0001773751-25-000035:0
100,000 shares@ US$2.430.9% of flowClass A Common StockSEC:0001773751-25-000032:0
27,098 shares@ US$2.430.2% of flowClass A Common StockSEC:0001773751-25-000025:0
300 shares@ US$2.430.0% of flowClass A Common StockSEC:0001773751-25-000019:0
33,668 shares@ US$2.430.3% of flowClass A Common StockSEC:0001773751-25-000012:0
176,308 sharesClass A Common StockSEC:0001773751-24-000394:0
176,308 sharesClass A Common StockSEC:0001773751-24-000403:0
33,513 shares@ US$33.37974.1% of flowClass A Common StockSEC:0001773751-24-000380:0
81,114 shares@ US$20.06655.8% of flowClass A Common StockSEC:0001773751-24-000344:0
188,888 shares@ US$2.431.6% of flowClass A Common StockSEC:0001773751-24-000312:0
42,099 shares@ US$16.29222.4% of flowClass A Common StockSEC:0001773751-24-000305:0
176,308 sharesClass A Common StockSEC:0001773751-24-000300:0
188,888 shares@ US$2.431.6% of flowClass A Common StockSEC:0001773751-24-000283:0
25 of 76 declarations
About Dudum Andrew
Public sources identify Andrew Dudum as the co-founder, Chief Executive Officer, Chairman of the Board, and a director of Hims & Hers Health, Inc. The company’s proxy materials state that he has held those roles since the business combination that made Hims & Hers a public company, and that he has been the CEO and a director of Hims since September 2016. Those sources also say he co-founded Atomic Labs in 2013, where he helped create more than a dozen companies, and that he was named to Fortune’s 40 Under 40 in 2020. Sources: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000136/hims-20250425.htm
